Infection Control Market Size & Share, Industry Analysis 2032
Global Infection Control Market Size, Share & Growth Analysis Report, 2024-2032

Infection Control Market Share, Size, Trends, Industry Analysis Report, By Type (Equipment, Services, Consumables, Others); End-use; By Region; Segment Forecast, 2024 - 2032

  • Published Date:Jan-2024
  • Pages: 116
  • Format: PDF
  • Report ID: PM3241
  • Base Year: 2023
  • Historical Data: 2019-2022

Report Outlook

The global infection control market size and share was valued at USD 227.4 billion in 2023 and is expected to grow at a CAGR of 6.5% during the forecast period. The market is primarily being pushed by the increase of surgical procedures that demand intensive infection control. The increasing involvement of government agencies in the process of issuing guidelines to raise global awareness of effective prevention strategies is anticipated to contribute to market expansion over the forecast period.

Infection control is an academic sub-discipline of epidemiology concerned with the prevention or stopping of the spread of infections in healthcare facilities. It incorporates several policies and procedures aimed at reducing infection rates in hospitals and other healthcare settings. Depending on the microorganism, specific precautions are needed to prevent infection transmission. The indications for transmission-based precautions can take the form of standard precautions, contact precautions, droplet precautions, and airborne precautions.

Standard precautions, which include hand hygiene, apt patient placement, and personal protective equipment, are used for all patient care. Contact precautions are used for patients with known or suspected infections that can be transmitted via contact. In contrast, droplet precautions are used for patients with suspected or known infections that can be transmitted via air droplets. As such, healthcare facilities need to have the apt equipment to implement the standard precautions for all patients. The rising elderly population drives the demand for infection control systems, impacting the infection control market favorably.

The market research report offers an in-depth analysis of the industry to support informed decision-making. It offers a meticulous breakdown of various market niches and keeps readers updated on the latest industry developments. Along with tracking the infection control market on the basis of SWOT and Porter’s Five Forces models, the research report includes graphs, tables, charts, and other pictorial representations to help readers understand the key insights and important data easily.

Infection Control Market Size

Know more about this report: Request for sample pages

Acute Respiratory Disorders (ARDs) are one of the main reasons for high mortality rates globally, according to data released by WHO. A whopping 4.0 million people die each year as a result of ARDs. The tremendous requirement for strict prevention and control is demonstrated by the data. Most hospital-acquired infections are caused by diseases like pneumonia and infections of the bloodstream, urinary tract, surgical site, and MRSA. Other significant hospital-acquired infections (HAI) include pneumonia linked to ventilators, catheter-related bloodstreams, and catheter-associated urinary tract infections. One of the main issues, which impacts patient recovery and has a significant effect on death rates internationally, is thought to be HAI.

The increase in hospitalization time for surgical infections was determined to be about 8 days, according to the WHO's practical guide on the prevention of HAI. The overall expenditures associated with hospitalization are expected to increase significantly as a result of these extended stays, which increases the clinical urgency for adopting infection prevention strategies. As a result of the excessive use of resources to treat the acquired infection, it is assumed that lengthy hospital stays are also not cost-effective for hospitals and healthcare payers.

The global infection control market is competitive and moderately fragmented. To increase their market share, industry participants are concentrating on new product releases, product developments, and global growth. Fortive (Advanced Sterilization Products), 3M Company, Getinge AB, Steris PLC, and Cantel Medical Corporation are some of the major market participants active in the market.

Industry Dynamics

Growth Drivers
Age-related population growth has been a notable trend in recent years. Older people are more susceptible to developing a variety of chronic diseases, including cancer, arthritis, chronic obstructive pulmonary disease (COPD), dementias, neurovascular diseases, and others. Those who are elderly are also more susceptible to hospital-acquired infections. This sizable group of senior citizens is prone to various chronic diseases, necessitating the use of infection control solutions while receiving treatment. As a result, as the world's elderly population rises, so does the demand for infection control solutions, driving the infection control market growth.

Medical equipment and pharmaceutical packaging materials are frequently sterilized by e-beam irradiation, sometimes referred to as beta irradiation. Very dense materials should not be used for this sterilization; low to medium density items work best. It advantages from clean, simple on/off technology and quick switch terminal sterilization. Radiation compatibility issues cannot occur since products can be sterilized using an e-beam for a short time. E-beam sterilizing reduces handling and related dangers and often takes five to seven minutes to finish. As a result, it is projected that the infection control market would develop significantly over the course of the forecast period.

Hospital-acquired infections (HAIs) are nosocomial infections that occur during a patient's stay at hospitals and related facilities and are not observed at the time of admission. They are a major cause of morbidity and mortality worldwide. These infections are primarily hospital-acquired pneumonia infections, central line-associated bloodstream infections, surgical-site infections, catheter-associated urinary tract infections, Clostridium difficile infections, and ventilator-associated pneumonia. One of the major causes of HAIs is the use of infected medical devices during diagnostic and therapeutic procedures.

Infection Control Market size

Report Segmentation

The market is primarily segmented based on type, end-use, and region.

By Type

By End-use

By Region

  • Equipment
  • Services
  • Consumables
  • Others
  • Hospitals
  • Medical Device Companies
  • Clinical Laboratories
  • Pharmaceutical Laboratories
  • Others


  • North America (U.S., Canada)
  • Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
  • Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
  • Latin America (Brazil, Mexico, Argentina)
  • Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

Know more about this report: Request for sample pages

Consumables segment is expected to grow dominantly over the projected period

Consumables are expected to hold a large percentage of the market as a result of their frequent use and limited product lifespans. Consumables are used frequently in sterilization, disinfection, and other control operations and are a necessary component of those treatments, therefore they make up a bigger portion of the total. As of 2022, personal protection equipment had a sizable percentage under consumables. Many healthcare organizations are arguing for and raising awareness of the advantages of personal protection equipment, which is expected to account for a sizeable percentage

In 2022, the hospitals segment dominated the market, accounting for the largest market share.

The substantial share is majorly a consequence of the high probability of acquiring infections in hospital premises through respiratory or bloodborne pathogen transmission. HAIs are one of the major challenges and thus require stringent control. This has urged hospitals and public health organizations to adopt highly efficient control systems. Also, as per research published in NCBI, 40% to 60% of hospital infections were estimated to be of surgical sites.

One of the main worries is the high risk of infection from bloodborne pathogens, drug-resistant bacteria, and other pathogens in the operating room. For instance, using urinary catheters frequently increases the incidence of UTIs and can lead to catheter-associated (CA)-UTIs. 25% of all bacterial infections are UTIs, according to research that was published in NCBI. The majority of hospital-acquired UTIs are linked to catheterization, and CA-bacteriuria is the most common HAI globally, accounting for up to 40% of HAIs in the U.S. each year, according to statistics from the National Nosocomial Infection Surveillance (NNIS) system report. These elements are anticipated to increase the market's potential for future growth.

Infection Control Market Size

The demand in North America is expected to witness significant growth.

The larger share seized by this area is thought to be due to a steady number of strategic collaborations adopted by key market players to expand their product range and infection control capabilities. Also, the established businesses' increased efforts to expand their presence throughout this region are to blame for North America's leading market share.

Due to the rising number of outsourcing companies, rising healthcare spending, and significant changes in healthcare infrastructure, the market in Asia Pacific is anticipated to develop at the quickest rate throughout the forecast period.

Infection Control Market share

Competitive Insight

Some of the major players operating in the global infection control market include 3M Company, Belimed AG, Halyard Health, Getinge Group, Matachana Group etc.

Recent Developments

  • In March 2017, 3M signed an agreement with Kimberly-Clark Health Care to develop and deliver surgical and infection prevention solutions utilizing their respective expertise.

Infection Control Market Report Scope

Report Attributes


Market size value in 2024

USD 241.82 billion

Revenue Forecast in 2032

USD 400.81 billion


6.5% from 2024 - 2032

Base year


Historical data

2019 – 2022

Forecast period

2024 - 2032

Quantitative units

Revenue in USD billion and CAGR from 2024 to 2032

Segments Covered

By Type, By End-use, By Region

Regional scope

North America, Europe, Asia Pacific, Latin America; Middle East & Africa

Key Companies

3M Company, Belimed AG, Halyard Health, Getinge Group, Matachana Group

We provide our clients the option to personalize the Infection Control Market report to suit their needs. By customizing the report, you can get data as per your format and definition. Also, the customization option allows you to gain a deeper dive into a specific segment, region, customer, or market competitor. Request for Report Customization Here


The infection control market report covering key segments are type, end-use, and region.

Infection Control Market Size Worth $400.81 Billion By 2032.

The global infection control market expected to grow at a CAGR of 6.5% during the forecast period.

North America is leading the global market.

key driving factors in infection control market are increase of surgical procedures that demand intensive infection control.